The Alzheimer’s Treatment Controversy: Implications of Accelerated Drug Approvals Live Online Q&A with Aaron Kesselheim, Professor of Medicine, Harvard Medical School, and Director, Program On Regulation, Therapeutics, And Law (PORTAL), Brigham and Women’s Hospital Presented jointly with Reuters Tuesday, July 20, 2021 The recent controversy surrounding the FDA approval of a new Alzheimer’s treatment has Read More…
DRUG TRIALS: Challenges for Alzheimer’s and Other Urgent Needs Presented in Partnership with HHMI Tangled Bank Studios and In Collaboration with STAT In Association with NOVA This Forum explored the challenges and complexities of drug trials, and how they impact disease treatment and prevention — particularly for conditions that currently have little Read More…
[FORUM VIDEO] This Forum event explored the latest science in nutrition, exercise, cognition and social connectedness to promote healthy and happy aging.
[FORUM VIDEO] This Forum event examined the results of a new poll conducted by the Harvard School of Public Health and Alzheimer Europe on perception and awareness of the disease among residents in the U.S., Germany, France, Spain and Poland – and their views on the value of diagnosis.
